Install
FirstWord
- 112articles · 30d
- 2+ hour agolatest article
- Aug 14, 2026earliest in window
- 0%with images
- 13avg words
- HTH 91
- health 74
- HW 66
- BI 41
- economy business and finance 26
- FIB 17
- science and technology 10
- NW 4
Please confirm you are human
This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.
A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.
News
Spotlight On: Key questions emerging from ESC 2026
1+ week, 3+ day ago (10+ words) FirstWord Pharma...
Network Bio launches with $50M to read the???barcodes??? of disease
3+ week, 3+ day ago (13+ words) Network Bio launches with $50M to read the ‘barcodes’ of disease FirstWord Pharma...
Spotlight On: What to watch at World Lung 2026
3+ day, 13+ hour ago (10+ words) firstwordpharma.com...
Acting heads of FDA centres land permanent gigs, plus new AI leader
4+ day, 17+ hour ago (14+ words) FirstWord Pharma...
Friday Five??? Cancer vaccine aims hit target, MAHA mainstay tapped to run FDA, AstraZeneca's hits soften a miss???and more
3+ week, 2+ day ago (22+ words) Friday Five – Cancer vaccine aims hit target, MAHA mainstay tapped to run FDA, AstraZeneca's hits soften a miss…and more FirstWord Pharma...
Friday Five??? Novartis' stumbles spark boardroom backlash, Nodthera name drops, FDA throws wrench into Biohaven deal???and more
2+ day, 18+ hour ago (19+ words) Friday Five – Novartis' stumbles spark boardroom backlash, Nodthera name drops, FDA throws wrench into Biohaven deal…and more firstwordpharma.com...
AI analysis from Brainomix adds to evidence backing Endeavor's IPF therapy
4+ day, 21+ hour ago (13+ words) FirstWord PHARMA...
KOL Views Preview: What implications does milvexian's failure in Librexia ACS have on the factor XIa class?
1+ week, 4+ day ago (19+ words) FirstWord Pharma...
Spotlight On: SERENA-4 miss raises broader concerns over AZ's pipeline
2+ hour, 46+ min ago (12+ words) FirstWord Pharma...
GSK pays up to $1.3B for HUTCHMED's experimental KRAS-EGFR conjugate
1+ week, 3+ day ago (12+ words) FirstWord PHARMA...